VA-HILTON
24.1.2022 14:02:12 CET | Business Wire | Press release
Well-positioned to emerge from the pandemic stronger than ever, Hilton delivered a record year of development achievements. Already one of the world’s largest hotel companies, Hilton opened 414 properties, adding more than 67,100 rooms to its system, further emphasizing the scale, presence and leading brands of the company’s global portfolio.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220121005394/en/
“After a year of recovery and growth, it has been incredible to witness the resiliency of the travel industry and our team’s ability to embrace change while serving more guests in more hotels around the world,” said Chris Nassetta, President and CEO, Hilton. “We believe the desire to travel, experience new cultures and connect with others is core to the human experience. I can speak for all of us at Hilton when I say we’re looking forward to welcoming our guests and helping them make new memories in 2022.”
Global development efforts have continued to show strong performance through the pandemic. Hilton ended 2021 with more than 6,800 hotels across 18 brands in six continents, with robust net unit growth of 5.6%. The company’s development pipeline includes nearly 2,670 hotels representing approximately 408,000 rooms, nearly half of which are under construction.
“Hilton’s development continues to be a key performance indicator of how well-positioned we are for the long-term,” said Kevin Jacobs, CFO and president, global development, Hilton. “Hotel owners choose to work with us because of our premium commercial performance. With our capital light business model, we strive to maximize net unit growth, while continuing to deliver value for all our stakeholders.”
Celebrating A Year of Market and Category Milestones
- Historic Las Vegas Development: Hilton notably expanded its presence in the Las Vegas market, which is now home to 13 brands, including all three of our luxury brands, 36 hotels and more than 12,000 rooms. In June 2021, Hilton and Genting Group partnered in the historic opening of Resorts World Las Vegas , the largest multi-brand resort in Hilton’s history, integrating three premium brands – the largest Conrad Hotels & Resorts property in the world, one of the first LXR Hotels & Resorts locations in the U.S. and a marquee Hilton Hotels & Resorts hotel. Additionally, Curio Collection by Hilton re-emerged in Las Vegas with the introduction of Virgin Hotels Las Vegas, Curio Collection by Hilton .
- Significant All-Inclusive Expansion: Hilton’s all-inclusive portfolio expanded in 2021 with openings in the Caribbean and Latin America, including Hilton Cancun, an All-Inclusive Resort, Hilton Vallarta Riviera All-Inclusive Resort , Mangrove Beach Corendon Curaçao All-Inclusive Resort, Curio Collection by Hilton and The Yucatan Playa del Carmen All-Inclusive Resort, Tapestry Collection by Hilton .
- Hilton’s lifestyle brands gained momentum in Europe, the Middle East & Africa (EMEA) and Brazil. Canopy by Hilton made its debuts in France, UK and Spain. Motto by Hilton announced plans to open its first hotel in Europe with Motto Rotterdam Blaak in the Netherlands in 2022. Additionally, Brazil welcomed two Hilton brands with the debuts of Canopy by Hilton Sao Paulo Jardins and Almenat Hotel, Tapestry Collection by Hilton .
- Asia Pacific Growth: Hilton Nagasaki ’s flagship opening marked the company’s 500th hotel in Asia Pacific, while Hilton Lanzhou City Center ’s opening marked the 400th hotel in the Greater China and Mongolia region.
- Washington, D.C. Expansion: The company introduced its 25th hotel within the portfolio in Washington, D.C. with the debut of Hilton Washington DC Capitol Hill .
Recognizing Year of “Firsts” for the Brand Portfolios with Market Expansions
- Waldorf Astoria Hotels & Resorts expanded the brand’s West Coast presence with the opening of Waldorf Astoria Monarch Beach Resort & Club in Dana Pointe, California and signed a milestone management agreement with Orix Real Estate Corporation to expand the brand into Osaka, Japan in 2025.
- Management agreement was signed for the first Conrad Hotels & Resorts property in California with Conrad Los Angeles (opening Spring 2022) as well as the first in Tulum with Conrad Tulum Riviera Maya .
- LXR Hotels & Resorts was introduced in Africa and the Indian Ocean with Mango House Seychelles and in Asia Pacific with ROKU KYOTO, LXR Hotels & Resorts .
- Signia by Hilton debuted with the conversion and rebrand of Signia by Hilton Orlando Bonnet Creek . Additionally, Signia by Hilton Atlanta broke ground at Georgia World Congress Center.
- Curio Collection by Hilton surpassed 100 properties worldwide with the opening of Sable at Navy Pier Chicago, Curio Collection by Hilton .
- DoubleTree by Hilton extended its international reach to its 50th trading market with the opening of DoubleTree by Hilton Frankfurt Niederrad, the brand’s first in Germany.
- Tapestry Collection by Hilton introduced properties in Europe and the Chinese Mainland, including Atocha Hotel Madrid, Tapestry Collection by Hilton and Hollick Hotel Wen’an, Tapestry Collection by Hilton .
- Motto by Hilton announced plans to open its first hotels in Europe and Latin America in 2022 with Motto Rotterdam Blaak in the Netherlands and Motto Tulum in Mexico.
- Hilton Garden Inn entered into Australasia, South Korea, Thailand and Indonesia’s capital city Jakarta with Hilton Garden Inn Albany , Hilton Garden Inn Seoul Gangnam , Hilton Garden Inn Phuket Bang Tao and Hilton Garden Inn Jakarta Taman Palem , respectively. Additionally, the brand launched its large-scale franchise model in China , welcoming investors and independent owners to explore franchising opportunities.
- Hampton by Hilton celebrated milestones throughout the year, surpassing 2,700 open hotels and expanding into Ireland, Uzbekistan and Qatar, as well as the Cayman Islands with Hampton by Hilton Grand Cayman . Hampton also remains the fastest-growing international hotel brand in China, marking 200 open hotels, with an additional 600 signed development deals within the country. Additionally, starting 2022 strong, the brand was recognized for the 13th year in a row as the No. 1 hotel franchise by Entrepreneur ’s Franchise 500® , tying the record for most total No. 1 rankings in the Hotels & Motels category.
- Tru by Hilton opened its 200th hotel, adding nearly 100 hotels during the pandemic, and announced expansion into the Caribbean and Latin America, with developments in Brazil, Costa Rica, Dominican Republic, Mexico and Puerto Rico.
- Homewood Suites by Hilton unveiled a comprehensive brand refresh with a game-changing, all-new prototype – ‘Prototype 10.0’ – designed to offer added value and versatility for owners and developers, while exceeding the needs of guests who want the comforts of home.
- Home2 Suites by Hilton became one of the fastest-growing hotel brands as it reached 500 open properties in just 10 years and touts the largest pipeline in the U.S., with 437 properties in development. The brand also debuted in China , with the opening of the first of 1,000 Home2 Suites by Hilton properties in the region.
In addition to development milestones, Hilton continued to innovate to meet the evolving needs of travelers with the introduction of industry-leading programs and products, such as Confirmed Connecting Rooms by Hilton and Hilton Honors Digital Key Share , and the evolution of brand standards, including expanding its pet-friendly offerings . To learn more, visit newsroom.hilton.com .
About Hilton
Hilton (NYSE: HLT) is a leading global hospitality company with a portfolio of 18 world-class brands comprising more than 6,800 properties and more than 1 million rooms, in 122 countries and territories. Dedicated to fulfilling its founding vision to fill the earth with the light and warmth of hospitality, Hilton has welcomed more than 3 billion guests in its more than 100-year history, earned a top spot on the 2021 World’s Best Workplaces list and been recognized as a global leader on the Dow Jones Sustainability Indices for five consecutive years. In 2021, in addition to opening more than one hotel a day, Hilton introduced several industry-leading technology enhancements to improve the guest experience, including Digital Key Share, automated complimentary room upgrades and the ability to book confirmed connecting rooms. Through the award-winning guest loyalty program Hilton Honors, the nearly 128 million members who book directly with Hilton can earn Points for hotel stays and experiences money can’t buy. With the free Hilton Honors app , guests can book their stay, select their room, check in, unlock their door with a Digital Key and check out, all from their smartphone. Visit newsroom.hilton.com for more information, and connect with Hilton on Facebook , Twitter , LinkedIn , Instagram and YouTube .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220121005394/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 12:38:00 CEST | Press release
For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will
Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital18.9.2026 11:48:00 CEST | Press release
Estithmar Holding Q.P.S.C. announced the completion of the transfer of a 48.68% stake in Shahba Bank to Masaref Holding LLC, subsidiary of Estithmar Capital, Estithmar Holding’s financial services and investments arm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918807909/en/ Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital (Photo: AETOSWire) As a shareholder, Masaref Holding intends to support the assessment of proposals aimed at strengthening Shahba Bank’s financial, operational and technological capabilities, including potential capital enhancement, branch network expansion, and the development of products and services for individuals, businesses and SMEs. The proposals may include modernizing banking and operational systems, develop digital services, and strengthen governance, compliance, risk management and cybersecurity to enhance
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
